<SEC-DOCUMENT>0001493152-18-016244-index.html : 20181115 <SEC-HEADER>0001493152-18-016244.hdr.sgml : 20181115 <ACCEPTANCE-DATETIME>20181115103914 ACCESSION NUMBER: 0001493152-18-016244 CONFORMED SUBMISSION TYPE: NT 10-Q PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181115 DATE AS OF CHANGE: 20181115 EFFECTIVENESS DATE: 20181115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Adhera Therapeutics, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 181186256 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-578-5901 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Marina Biotech, Inc. DATE OF NAME CHANGE: 20100722 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>NT 10-Q <SEQUENCE>1 <FILENAME>formnt-10q.htm <TEXT> Document 1 - file: formnt-10q.htm
</DOCUMENT> </SEC-DOCUMENT>